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Chaksyu is the Pradhana-anga that is affected in Diabetic retinopathy. So 
the Netra Rakshana is highly essential for the human being in Diabetic 
retinopathy. Now-a-Days Diabetic retinopathy is a major vision 
threatening factor. The prevalence rates are; Diabetic retinopathy 
(34.6%), Proliferative Diabetic retinopathy (7%), diabetic macular 
oedema (6.8%) and Vision threatening Diabetic retinopathy (10.2%). To 
treat the disease we need to know the level of impairment, the signs and 
its etiopathology. In Ayurved it is very important to know the Samprapti 
before treating the disease. Now-a-days Pratyaksha gyana plays a vital 
role to trace out the disease. Complain of the patient, sign and symptom 
of the disease along with the pathogenesis is necessary to diagnose and 
to treat the disease. The features occurs in the fundus in Diabetic 
retinopathy cannot visualize by Pratyaksha, explained in classical 
literatures. Many ophthalmic investigations, procedures have been 
developed so far like fundoscopy, OCT, B’scan, fluorescent test etc. to 
detect the pathology occurred in the fundus of Diabetic retinopathy eyes. 
So it is very important for all Shalaki is to correlate the disease, to derive 
a conclusion according to the Ayurvedic Samprapti/ pathogenesis and 
terminology described in classical literatures. By analyzing the Samprapti 
of the disease we can conclude that, the pathology occurred in fundus are 
most probably due to the Dhatu-kshaya janya, Urdhwaga-raktapittaja, 
Mandagni janya and Avarana janya. Diabetic retinopathy can be 
correlated with Pramehaja Timira and its treatment is the treatment of 
Prameha explained in classics having Chakshushya property. 
 
INTRODUCTION 
To understand a disease, we have to know 
its pathology and pathological changes that is 
occurring inside the body. By comparing the 
changes with the normal structures and functions 
with the abnormal, we can easily diagnose a 
disease. According to modern Ophthalmology 
microvascular changes occurs in fundus of eye in 
Diabetic Retinopathy. Those changes can’t be 
perceived without the help of modern technology 
and procedures. Pratyaksha is the most important 
tool to diagnose a disease. Till the invention of 
modern logistics and procedures it was very 
difficult to do Pratyaksha. By making Anumana from 
the symptoms which are told by the patients, it was 
very difficult to predict or diagnose a disease. Now 
by the development of procedures like Fundoscopy, 
OCT, B’scan, FFA tests, we can easily diagnose the 
Diabetic retinopathy. The various signs and 
symptoms of Diabetic retinopathy can be correlated 
with the Lakshana of Dhatu-kshaya, Urdwaga-
Raktapitta, Avarana (Pranavritta-Vyana) etc. The 
symptoms of Diabetic retinopathy may be similar to 
the Kacha, Timira, Linganasha, Dhumadarshi etc. So 
it is very essential to co-relate the etio-pathology 
and to interpret them with the terms of Ayurved. 
Now-a-days most of the Ayurved physicians are 
diagnosing the disease using modern technology 
and procedures. And by correlating them with 
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Ayurvedic Samprapti, it is easier for us to treat them 
with Ayurvedic principle and therapeutics. 
Description 
Diabetic retinopathy is a chronic progressive 
sight-threatening disease of retinal micro-
vasculature which is associated with prolonged 
hyperglycemia and other conditions linked to 
Diabetes such as hypertension. 
Pathogenesis[1] 
In Diabetic retinopathy the retinal precapillary 
arterioles, capillaries and venules are affected. 
Hyperglycemia produces damage to the cell of 
retina, endothelial cells, loss of capillary pericytes 
and thickening of capillary basement membrane 
causes capillary damage. The Microangiopathy 
affects the breakdown of Blood-Retinal-Barrier 
leading to retinal edema, hemorrhages, leakage of 
lipids i.e., hard exudates, micro-aneurysms, 
hemorrhages, ischaemia and IRMA. 
Classification of Diabetic retinopathy [1] 
The Diabetic Retinopathy can be classified into  
a. Non-proliferative Diabetic retinopathy  
i. Mild NP Diabetic retinopathy  
ii. Moderate NP Diabetic retinopathy  
iii. Severe NP Diabetic retinopathy  
b. Proliferative Diabetic retinopathy  
c. Diabetic Maculopathy 
d. Advanced diabetic eye disease (ADED) 
During the examination of fundus in Diabetic 
retinopathy, following clinical features are found as 
sign and symptom. 
Symptoms of Diabetic retinopathy  
 Blurred or distorted vision or difficulty 
reading 
 Floaters 
 Partial or total loss of vision 
 A shadow or veil across patient’s visual field 
 Eye pain 
Sign of NP diabetic retinopathy [2] 
A. Micro aneurysm 
B. Retinal hemorrhage  
i. “Dot or Blot” Spot 
ii. “Flame or Splinter shape” hemorrhage 
C. Hard exudate 
D. Cotton wool spot 
E. Venous beading 




Sign of proliferative Diabetic retinopathy [2] 
 Neovascularization 
 NVD (Neovascularization of Disc) 
 NVE (Neovascularization of Elsewhere) 
 Vitreous changes. 
Final Stage of Uncontrolled PDR 
 Glaucoma (Neovascularization). 
 Blindness from Persistent Vitreous 
Hemorrhage. 
 Tractional Retinal Detachment and Opaque 
Membrane Formation. 
Sign of Maculopathy[1] 
 Macular ischemia   
 Macular edema 
 Increased retinal vascular permeability.  
Management of Diabetic retinopathy[1] 
 Prevention of Diabetic retinopathy  
 Medical treatment 
 Control of systemic risk factors. 
 Providing pharmacological modulators like 
 Protein Kinase C – PKC 
 Vascular Endothelial Growth Factors - VEGF 
 Antioxidant like Vitamin E 
 Intravitreal anti-VEGF drugs like 
 Ranibizumab (0.5 mg) 
 Bevacizumab (1.25 mg) 
 Intravitreal Steroids. 
 Fluocinolone Acetonide Intravitreal 
Implant 
 Intravitreal Injection of Triamcinolone 
 Laser therapy 
 Macular Photocoagulation 
 Focal 
 Grid  
 Panretinal Photocoagulation (PRP) 
 Vitreoretinal Surgery 
Prevention 
 Proper Screening of Diabetic retinopathy - 
History taking, Fundoscopy, OCT, FFA etc. 
 Controlling blood sugar i.e., HbA1c must below 
7. 
 Controlling blood pressure i.e. systolic BP must 
below 130 mmHg. 
 Controlling lipid profile i.e., TG and LDL. 
 We have to correct the Anaemia. 
 We should control Diabetic Nephropathy 
 Pregnancy makes Diabetic retinopathy worsen. 
So we need to be careful during Pregnancy. 
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Ayurvedic Co-Relation of Diabetic retinopathy 
Diabetic retinopathy is not mentioned in our 
classics as separate disease but the symptoms 
which are told in Timira mainly in Prathama and 
Dwitiya Patala Gata Timira as Avyakta Darshana 
and Mashka in front of the eyes which can be taken 
as blurriness of vision and floaters probably caused 
due to hemorrhages in the retina. And as per 
mentioned by Pujyapada Muni in his work “Netra 
Prakashika” explains Timira as the Upadrava of 
Madhumeha. [3] 
Ayurved is basing on the principle of Dosha 
and Dhatu. While treating patients, Ayurved 
physicians always consider the Doshik and Dhatu 
imbalance. The Samprapti Vighatana helps in 
planning the treatment. In Diabetic retinopathy 
there are structural and functional abnormality of 
Sira and Dhamani are seen. Those features of 
vascular abnormality can be correlate with 
Urdwaga-Raktapitta (Netragata rakta srava/ 
Retinal Hemorrhage), Sira and Dhamani Saithilya 
(seen in Rakta and Mamsa Kshaya respectively) i.e. 
Dhatu Kshaya Janya. According to Astanga Hridaya 
“Madhumeha arises by two ways; 1. Due to Dhatu 
Kshaya causing aggravation of Vata Dosha and 2. 
Obstruction of the path of Vata by Doshas covering 
it”[4] i.e., the Avarana janya. In other way it is told 
that all the disease are originated due to 
Mandagni.[16] So the Samprapti (Ayurvedic etiology) 
can be explained under the following headings. 
1. Dhatu Kshaya Janya 
2. Avarana Janya 
3. Raktapitta Janya 
4. Mandagni janya 
1. Dhatu kshaya 
Oja is the essence of all the Dhatus.[5] The 
Oja Dhatu diminishes in Madhumeha ,[6] which is the 
cause of diminish/ Kshaya of all remaining Dhatus. 
Hence there will be Kshaya of Rakta and Mamsa 
Dhatu too. Sira Saithilya is the Lakshana of Rakta 
Dhatu Kshaya.[7,8] Dhamani Saithilya is the Lakshana 
of Mamsa Dhatu Kshaya.[9] Sira and Dhamani 
Saithilya indicates the dysfunction of the venules 
and arterioles. Dysfunction of those vessels can be 
expressed in terms of occlusion i.e., Central Retinal 
Artery Occlusion (CRAO), Branch Retinal Vein 
Occlusion (BRVO), Central Retinal Vein Occlusion 
(CRVO) Ischemia, leakage etc. In Diabetic 
retinopathy the sign are Micro Aneurysm, Retinal 
Hemorrhage, Venous Beading, Intra-Retinal 
Microvascular Abnormalities (IRMA) and Retinal 
Edema, which are nothing but the dysfunction of 
venules and arterioles. So the above clinical 
features occurring in Diabetic Retinopathy are 
interpreted as Dhatu Kshaya. 
2. Avarana janya 
In Raktavrit Vata there is reddish patches 
found over body[10] those reddish patches may be 
correlated with the pre-capillary arteriole bleed and 
the splinter hemorrhage occurring in fundus of 
Diabetic retinopathy. In Pranavritta Vyana Vayu 
there is Sunyata, it means the Indriya cannot 
perceive their Visaya i.e., Indriya Sunyata/ loss of 
vision in Diabetic retinopathy. The eye cannot 
perceive the subjects and it is to be treated like 
Urdhwajatrugata Rogas.[11] Prana Vayu controls the 
function of all other Vayus. So it also responsible for 
the visual perception. Vyana Vayu meant for Gati,[12] 
Rasa Vikshepana[13] and neural conduction. The 
circulation and visual conduction can be considered 
as the function of Vyana Vayu. So when the Gati of 
Vyana Vayu is obstructed by Prana vayu, the 
circulatory function and the neural conduction can 
also be hampered. There may be ischemia, 
occlusion, leaking and bleeding of the fundal vessels 
of the retina. The abnormality in Rasavikshepana 
can be considered as the hard exudates (the lipid) 
in the Retina. Due to the excessive deposit in 
macular region there will be macular edema. 
Sometimes the Cessation of Gati leads to 
Khavaigunya.[14,15] Kha’ means empty space which 
can be correlated with ischemia that leads to 
Neovascularization. By combining the Vikruti in 
Pranavritta Vyana Vayu there will be defect in 
vision caused due to the neovascularisation’s, 
exudates, ischemia, occlusion and leakage.  
So the above clinical signs indicating Avarana 
causing Diabetic Retinopathy.  
3. Raktapitta janya 
Rakta-Pitta is the disease in which there will 
be bleeding from different part of body. Based on 
the site of bleeding it is categorized in to Urdhwaga, 
Adhoga and Tirjag Rakta-Pitta. In Urdhaga 
Raktapitta there will be bleeding from the 
Jatrurdhwa structures like Mukha, Nasa and 
Chaksyu. Due to intake of Achakshyushya Dravya, 
the neutral Pitta and Rakta gets vitiated. Then the 
Dushita Pitta and Rakta get confined to the 
choroidal layer of eye and causes Intra-Retinal 
Microvascular Abnormalities (IRMA). This includes 
Micro-aneurysm, Retinal hemorrhage, (“Dot or Blot” 
Spot, “Flame or Splinter shape” hemorrhage), Hard 
exudate, Cotton wool Spot and Venous, bleeding. 
The above clinical features i.e., Retinal hemorrhage 
and Intra-Retinal Microvascular Abnormalities, 
IRMA which is the prime sign of Diabetic 
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retinopathy. This suggests that Diabetic retinopathy 
as the Urdhwaga Rakta-pitta Janya. 
4. Mandagni 
Roga sarbapi mandagnou.[16]: All the disease 
of human being are originated due to Mandagni. 
Mandagni produces Ama, the waste product. Dhatu 
produces the successive Dhatu by their respective 
Dhatwagni. And if there is Mandagni, the respective 
Sara Bhaga (the 7 Dhatu) and Kitta Bhaga (the 3 
Dosha)[17] of Dhatu cannot be formed properly and 
there will be deposition of Ama. This results in the 
improper production of the successive Dhatu and 
imbalance of Dosha. The Alochaka Pitta, which seats 
on the eye gets vitiated and causes the disturbance 
in perception of images which may be co-related 
with the blurriness or floaters i.e., Timira. And if this 
disturbance in perception associated with Prameha 
then it can be told as Pramehaja-Timira. 
 By combining all the clinical features of 
Diabetic retinopathy we can conclude that the 
pathology occurred in Retina of Diabetic 
retinopathy i.e., the structural and functional 
abnormality of micro vessels, are caused by the 
disturbance of Dosha i.e., Vata (Prana, Vyana Vayu), 
Pitta, Rakta (Urdhwaga Raktapitta), Dhatu (Rakta, 
Mamsa) Kshaya, Oja and Mandagni. 
Treatment of Diabetic retinopathy according to 
Ayurved 
Though the Madhumeha Janya Timira and 
its treatment is not explained directly in our 
classical literature, still we can treat the disease 
according to its Samprapti Vighatana as explained 
above. Drugs with the property of Chakshushya, 
used in Prameha/ Madhumeha will be chosen to 
treat the Prameha Janya Timira.   
The treatment Protocol will be  
1. Nidana-Paribarjana (Nidanakara Ahara/ Vihara 
of Prameha and Timira)  
2. Sodhana and Sansamana Chikitsa of 




 Sthanika Karma 
 Tarpana 
 Ashchyotana 
 Nashya  
 Shirodhara  
 Sarbadahika karma  
 Virechana 
 Basti 
 Rasayana Chikitsa 
 Sebya Oushadhi 
 Kwatha 
 Rasaoushadhi 
 Rasayana Chikitsa 




The Srotas are usually obstructed by the 
deposition of Ama, hence the Sirovirechana i.e., 
Nashya karma with Chakshushya Dravya and Kaya 
virechana can be administered.  
Virechana[18] 
 In Vataja- Eranda Taila mixed with milk is given 
to treat it. Eranda Taila can be used to treat 
almost all the Avarana. 
 Rakta and Pittaja- Sarkara, Ela, Trivrut Choorna 
mixed with Madhu 
 Kaphaja- Pugadi Virechana is recommended  
Basti[19] 
Basti is considering as a therapy for both 
Sodhana and Samana. Yapana Basti, Yasthimadhu 
Ksheera Basti, Panchatikta Pancha Prasritika Basti 
and Guduchyadi Ksheera Basti may be administered 
in Pitta and Rakta Avarana. 
Basti and Virechana [20] 
Virechana and Basti with chakshushya drugs 
should be advocated to control Vata. Sothahara 
(anti-inflammatory) Basti can be instituted to 
reduce retinal/macular edema in general. In this 
context Madutailika Chakshushya Basti may be 
administered in Diabetic macular edema (DME) 
cases, as this Basti is beneficial in Raktapitta as well 
as this is Chakshushya in nature Triphala Ghrita; 
Virechana Yoga (Triphala, Trivrita and Katuki), 
Takradhara (Takra and Amalaki), Pratimarsha 
Nasya (Anutaila), Rasayana Yoga.[21] 
Nashya- Dhara- Lepa 
Nasya, Shirodhara, Shirolepa and Shiropichu 
treatments can be given in different stages of 
Diabetic retinopathy on the principle of “Vata 
shaman treatment for head and body and pitta 
Shaman treatment for eyes”.[22] 
Tarpana 
The Patoladi ghrita, Jivantyadi ghrita and 
Drakshyadi ghrita can be used as Tarpana. The 
Raktapitta Samaka, Ropaka and Rasayana 
properties of these drugs reduces the hemorrhagic 
signs.  
Tarpana with Doorvadya ghrita is effective 
in mild to severe NP Diabetic retinopathy and 
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Proliferative Diabetic retinopathy (i.e., Rakta 
pittaja).[23] 
Triphala has anti VEGF properties. So the 
Mahatriphala Ghrita can be used in 
neovascularisation of Proliferative Diabetic 
retinopathy, Pranavritta Vyanaja.[24] 
Patoladi ghrita Tarpana[25] and Jivantyadi 
Ghrita Tarpana can be used in retinal ischemic 
conditions of Diabetic retinopathy, Dhatukshya-
janya.[26] 
Aschyotana 
Prapoundarikadi[27] and Manjisthadi[28] 
Ashchyotana can be used in NP Diabetic retinopathy 
cases. 
Shamshamana Chikitsa 
Phalatrikadi Kwatha pana[29] (equal quantity 
of-Haritaki, Vibahtaki, Amalaki, Daruharidra, 
Haridra, Indrayava, Mustha). 
Mahavasadi Kwatha[30] (equal quantity of 
drugs of Mahavasadi Kwatha-Vasa, Nimba, Patola 
Patra, Katuki, Guduchi, Raktachandna, Kutaja, 
Indryayava, Daruharidrya, Shunthi, Triphala, and 
Bhunimba). 
Maharishi Charaka mentioned to use 
Mantha, Kashaya, Yava choorna leha and Laghu 
ahara sevana which is easily digestible in Prameha. 
Triphaladi choorna, Triphaladi Kwatha, 
Mahavasadi Kwatha,[31] Vasakadi Kwatha[32] and 
Amrutadi Guggulu. [33] 
Rasayana Chikitsa / Antioxidants 
In Diabetic retinopathy modern modality 
includes Antioxidants. In Ayurved we have many 
Ayurvedic preparations having Antioxidant 
property. Those can be used for this purpose. 
 Amalakayas Rasayana [34] 
 Aswagandharishtam [35] 
 Sitopaladi choorna[36] 
 Dashmolarishtam (aqueous extract) [36] 
 Triphala Guggulu (methanolic extract)[36] 
 Arjuna ghrita (dimethyl sulfoxide extract) 36 
 Giloy Satva (hydro alcoholic extract)[36] 
 Vayasthapana Rasayana (Methanolic extract)[36] 
 Nisha-amalaki (aqueous extract) [36] 
 Drakshavleha (Methanolic extract)[36] 
 Manjisthadi choorna (Aqueous extract) [36] 
 Jeevaneeya Rasayana (Methanolic, ethanoic and 
water extract) [36] 
 Triphala (hydro alcoholic extract)[36] 
 Chavayanprash (ethyl acetate, methanolic and 
aqueous extracts) [36] 
 Punarnavasatak Kwatha[36] 
 Maha yogograj Guggulu [36] 
 Chandraprabha vati (Methanolic extract) [36] 
 Arogyavardhini vati [36] 
 Laxmivilas rasa (Aqueous extract) [36] 
The above medicines have the Rasayana 
property, so in Diabetic retinopathy, instead of 
modern antioxidants those Ayurvedic Antioxidants 
can be used. Those Ayurvedic Antioxidants can 
rejuvenates the microvasculature and restore their 
structure and function. 
The above modalities or treatment 
protocols can be used to treat the Pramehajanya 
timira i.e., Diabetic retinopathy which occurs 
because of the prolonged Prameha. 
DISCUSSION 
Madhumeha causes Oja Kshaya leading to 
Rakta and Mamsa Dhatu Kshaya which ultimately 
produces micro vascular abnormality in retina. In 
Avarana the Prana Vayu obstruct the Gati and 
function of Vyana Vayu, results in the dysfunction of 
retinal circulations causing the sign of Diabetic 
retinopathy. The defective circulation i.e., occlusion, 
ischemia and leakage causing the sign of Diabetic 
retinopathy, like Neovascularization, Retinal 
hemorrhage, Dot or Blot Spot, Splinter hemorrhage, 
Retinal edema etc. The Raktavrit Vata causes the 
pre-capillary arteriolar bleed and the splinter 
hemorrhage, which are the sign of Diabetic 
retinopathy. In Urdhwaga Raktapitta the bleeding in 
the retinal layer is due to Dhatu Kshaya and 
Avarana of Pranavritta Vyana Vayu. Among the 
treatment modalities the Virechana both Kaya and 
Siro Virechana along with Basti, Tarpana, 
Takradhara, Lepa,  Ashchyotana along with 
Vasakadi Kwatha, Mahavasadi Kwatha, Phalatrikadi 
Kwatha, Triphaladi choorna, Triphaladi Kwatha, 
Amrutadi Guggulu, Prapoundarikadi and 
Manjisthadi, Eranda Taila, Patoladi ghrita, 
Jivantyadi ghrita, and Drakshyadi ghrita with the 
Ayurvedic antioxidants, the Rasayana Oushadhi are 
useful to treat the Diabetic retinopathy. 
CONCLUSION 
Diabetic retinopathy is more prevalent 
among the chronic Diabetic patients. Hence before 
treating we should know the pathogenesis of the 
disease. Pratyaksha of Dhatu Kshaya, Avarana of 
Vata and Urdhwaga Rakta-Pitta of the retinal layer 
can only be perceived by fundoscopy, FFA, OCT, 
B’SCAN, which are the diagnostic procedures. To 
treat the disease according to the Ayurvedic 
Principles/protocol, we must follow the Ayurvedic 
pathogenesis/Samprapti. With the Pratyaksha of 
the above clinical signs through the diagnostic 
procedures we can interpret those through 
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Ayurvedic terminologies and we can treat them 
accordingly. Basing on the above description we can 
conclude that the Diabetic retinopathy are caused 
due to the disturbance of Agni, Dosha (Vata, Pitta 
and Rakta) and Dhatu (Rakta and Mamsa) which 
can be managed with the treatment described for 
Timira and Prameha/Madhumeha  having 
Chakshushya property along with the Rasayana 
Oushadhi as the Ayurvedic Antioxidants.  
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